a16z | AI at the Intersection of Bio | Vijay Pande, Surya Ganguli & Bowen Liu @a16z | Uploaded October 2024 | Updated October 2024, 1 hour ago.
In this episode, Vijay Pande is joined by AI experts Surya Ganguli, venture partner, and Bowen Liu, investment partner, to explore the transformational role of AI in drug discovery and biology. Together, they delve into how machine learning and self-supervised models are reshaping the foundational tasks of drug design, from protein folding to molecular synthesis. The conversation highlights cutting-edge breakthroughs like generative AI for drug discovery and the growing potential of foundation models to accelerate innovation. For biotech entrepreneurs, this episode offers an essential overview of how AI is untangling the complexity of biology, paving the way for faster, cheaper, and more effective drug development. Tune in to gain timely insights on the future of AI in healthcare and actionable takeaways that can sharpen your competitive edge in the rapidly evolving landscape of life sciences innovation.
Resources:
Find Vijay on X: https://x.com/vijaypande
Learn more about a16z Bio+Health: a16z.com/bio-health
Learn more about Raising Health: a16z.com/podcasts/raising-health
Stay Updated:
Find a16z Bio+Health on LinkedIn: linkedin.com/showcase/a16z-bio-health
Find a16z Bio+Health on X: https://x.com/a16zBioHealth
Subscribe on your favorite podcast app: a16z.com/podcasts/raising-health
Disclosure:
Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.
In this episode, Vijay Pande is joined by AI experts Surya Ganguli, venture partner, and Bowen Liu, investment partner, to explore the transformational role of AI in drug discovery and biology. Together, they delve into how machine learning and self-supervised models are reshaping the foundational tasks of drug design, from protein folding to molecular synthesis. The conversation highlights cutting-edge breakthroughs like generative AI for drug discovery and the growing potential of foundation models to accelerate innovation. For biotech entrepreneurs, this episode offers an essential overview of how AI is untangling the complexity of biology, paving the way for faster, cheaper, and more effective drug development. Tune in to gain timely insights on the future of AI in healthcare and actionable takeaways that can sharpen your competitive edge in the rapidly evolving landscape of life sciences innovation.
Resources:
Find Vijay on X: https://x.com/vijaypande
Learn more about a16z Bio+Health: a16z.com/bio-health
Learn more about Raising Health: a16z.com/podcasts/raising-health
Stay Updated:
Find a16z Bio+Health on LinkedIn: linkedin.com/showcase/a16z-bio-health
Find a16z Bio+Health on X: https://x.com/a16zBioHealth
Subscribe on your favorite podcast app: a16z.com/podcasts/raising-health
Disclosure:
Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.
